Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PATH Trial: Personalized Approaches in the Treatment of Head and Neck Cancer

NCT05373251 is registered in ClinicalTrials.gov with British Columbia Cancer Agency as lead sponsor.

NCT NCT05373251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05373251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PATH Trial: Personalized Approaches in the Treatment of Head and Neck Cancer
Lead sponsor
British Columbia Cancer Agency
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 31, 2022
Completion date
August 31, 2032
Enrollment
500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer